Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.

Journal of clinical pathology - 1 Apr 2013

Deans Zandra C, Bilbe Neil, O'Sullivan Brendan, Lazarou Lazarus P, de Castro David Gonzalez, Parry Suzanne, Dodson Andrew, Taniere Philippe, Clark Caroline, Butler Rachel

Abstract excerpt

BACKGROUND: The clinical need to determine the presence of epidermal growth factor receptor (EGFR) gene mutations in non-small-cell lung cancers (NSCLC) in order to make informed decisions for patient treatment has seen the widespread introduction of EGFR molecular testing in many laboratories. To ensure high-quality molecular testing and allow laboratories to externally measure the standard of the service, an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diagnostic Errors
Share to Fixatives

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Formaldehyde

Share to Observer Variation

Share to Paraffin Embedding

Share to Pilot Projects

Share to Tissue Fixation

Share to United Kingdom

Source

Identifiers

PMID: 23378269
DOI: 10.1136/jclinpath-2012-201227

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.PMID 23378269Read ↗

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.Semantic proximity Read ↗

Results of a worldwide external quality assessment of cfDNA testing in lung Cancer.Semantic proximity Read ↗

Results of the First Italian External Quality Assurance Scheme for somatic EGFR mutation testing in non-small-cell lung cancer.Semantic proximity Read ↗

Results of a worldwide External Quality Assessment of cfDNA testing in Lung CancerSemantic proximity Read ↗

External quality assessment for EGFR mutations in Italy: improvements in performances over the timeSemantic proximity Read ↗

What's in a Name? A Coordinated Approach toward the Correct Use of a Uniform Nomenclature to Improve Patient Reports and Databases.Semantic proximity Read ↗

External quality assessment for EGFR exon 20 mutation testing in patients with non-small cell lung cancer in Spain.Semantic proximity Read ↗

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA.Semantic proximity Read ↗

External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years.Semantic proximity Read ↗

Quality Assessment of Reporting Performance for EGFR Molecular Diagnosis in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Higher quality of molecular testing, an unfulfilled priority: Results from external quality assessment for KRAS mutation testing in colorectal cancer.Semantic proximity Read ↗

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.